T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Scholar Rock
SRRK
$6.46B
| $46.3M | 0.01% |
8,436,185
+2,704,442
| +47% | +$19.4M |
|
|
RPC
902
Ridgepost Capital
RPC
$988M
| $45.5M | 0.01% |
4,089,508
+1,226,920
| +43% | +$14.1M |
|
903
Pacific Biosciences
PACB
$357M
| $45.5M | 0.01% |
10,284,090
+4,179,997
| +68% | +$25.4M |
|
904
HP
HPQ
$28.6B
| $45.1M | 0.01% |
1,376,144
-194,483
| -12% | -$7.14M |
|
905
MKS Inc
MKSI
$20.7B
| $45M | 0.01% |
438,951
+2,195
| +0.5% | +$256K |
|
906
Grocery Outlet
GO
$1.07B
| $45M | 0.01% |
1,056,405
-294,216
| -22% | -$10.8M |
|
|
AIRC
907
DELISTED
Apartment Income REIT Corp.
AIRC
| $45M | 0.01% |
1,082,471
-557,666
| -34% | -$25.9M |
|
|
NVRO
908
DELISTED
NEVRO CORP.
NVRO
| $44.7M | 0.01% |
1,019,432
-2,073,827
| -67% | -$114M |
|
909
RH
RH
$3.4B
| $44.5M | 0.01% |
209,802
-411,855
| -66% | -$122M |
|
|
REVHU
910
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
| $44.4M | 0.01% |
4,524,232
-458,036
| -9% | -$4.5M |
|
|
AMK
911
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $44M | 0.01% |
2,346,527
+105,988
| +5% | +$2.12M |
|
912
Curtiss-Wright
CW
$25.4B
| $44M | 0.01% |
333,253
-18,926
| -5% | -$2.69M |
|
913
Twist Bioscience
TWST
$7.86B
| $44M | 0.01% |
1,258,394
+120,489
| +11% | +$4.27M |
|
914
WillScot Mobile Mini Holdings
WSC
$4.17B
| $43.9M | 0.01% |
1,353,294
+1,146,708
| +555% | +$40.6M |
|
915
Johnson Controls International
JCI
$91.7B
| $43.7M | 0.01% |
912,346
-108,961
| -11% | -$6.07M |
|
|
BOAC.U
916
DELISTED
Bluescape Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
BOAC.U
| $43.7M | 0.01% |
4,306,952
-1,119,779
| -21% | -$11.2M |
|
917
Inspire Medical Systems
INSP
$1.68B
| $43.6M | 0.01% |
238,929
+5,338
| +2% | +$1.06M |
|
918
Revolution Medicines
RVMD
$43.3B
| $43.6M | 0.01% |
2,237,854
-61,962
| -3% | -$1.21M |
|
919
BioMarin Pharmaceuticals
BMRN
$13.3B
| $43.5M | 0.01% |
524,819
-1,064,526
| -67% | -$84.8M |
|
920
FormFactor
FORM
$10.3B
| $43.4M | 0.01% |
1,121,559
-73,408
| -6% | -$2.83M |
|
|
NLSN
921
DELISTED
Nielsen Holdings plc
NLSN
| $43.4M | 0.01% |
1,870,051
-4,951,047
| -73% | -$127M |
|
|
SAFM
922
DELISTED
Sanderson Farms Inc
SAFM
| $43.4M | 0.01% |
201,444
-159,608
| -44% | -$31.2M |
|
|
BSKYU
923
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
| $43.2M | 0.01% |
4,411,944
+23,788
| +0.5% | +$234K |
|
924
Zscaler
ZS
$30.4B
| $43M | 0.01% |
287,857
+40,334
| +16% | +$7.13M |
|
925
Consolidated Edison
ED
$40.1B
| $42.9M | 0.01% |
451,357
-47,977
| -10% | -$4.57M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.